AbbVie

E184183

AbbVie is a global biopharmaceutical company known for developing and marketing innovative therapies in areas such as immunology, oncology, and neuroscience.

All labels observed (2)

Label Occurrences
AbbVie canonical 23
ABBV 1

How this entity was disambiguated

Statements (50)

Predicate Object
instanceOf biopharmaceutical company ⓘ
multinational corporation ⓘ
public company ⓘ
acquired Allergan ⓘ
acquiredFrom Allergan shareholders ⓘ
acquisitionDate 2020-05-08 ⓘ
CEO Richard A. Gonzalez ⓘ
chairperson Richard A. Gonzalez ⓘ
country United States ⓘ
focusArea aesthetics ⓘ
eye care ⓘ
immunology ⓘ
neuroscience ⓘ
oncology ⓘ
virology ⓘ
women's health ⓘ
foundedBy Abbott Laboratories ⓘ
foundingDate 2013-01-02 ⓘ
headquartersLocation North Chicago, Illinois ⓘ
industry biotechnology ⓘ
pharmaceuticals ⓘ
ISIN US00287Y1091 ⓘ
legalForm corporation ⓘ
memberOf S&P 500 ⓘ
linked to: S&P 500 Index
notableProduct Botox (therapeutic and cosmetic) ⓘ
Humira ⓘ
Imbruvica ⓘ
Juvederm ⓘ
Rinvoq ⓘ
Skyrizi ⓘ
Venclexta ⓘ
numberOfEmployees over 50,000 ⓘ
operatesIn Africa ⓘ
Asia ⓘ
Europe ⓘ
Latin America ⓘ
Middle East ⓘ
North America ⓘ
parentCompanyAtFounding Abbott Laboratories ⓘ
researchFocus autoimmune diseases ⓘ
hematologic malignancies ⓘ
inflammatory bowel disease ⓘ
neurodegenerative diseases ⓘ
psoriasis ⓘ
rheumatoid arthritis ⓘ
solid tumors ⓘ
separatedFrom Abbott Laboratories ⓘ
stockExchange New York Stock Exchange ⓘ
tickerSymbol ABBV ⓘ
linked to: AbbVie
website https://www.abbvie.com ⓘ

How these facts were elicited

Referenced by (24)

Full triples — surface form annotated when it differs from this entity's canonical label.